A survey provides insights into the effects of COVID-19 on medical communications and the immediate and long-term adjustments being made as a result.
Part B of a two-part series delves into the practicalities of patient authorship and offers tips for effective and ethical patient collaboration.
Patient authorship is here and here to stay. Part A of a two-part series explores how sponsors may benefit from patient authorship, or risk getting left behind.
Find out more about how medical publication professionals make decisions about authorship order.
Find out more about ISMPP’s guidance for navigating author non-responsiveness in the wake of the coronavirus pandemic.
Listen to patient partnership specialist Lauri Arnstein’s perspectives on the role of patients in medical publishing.
Jackie Marchington gives her perspective on the Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations.
Dawn Lobban, Senior Scientific Lead at Alligent Europe, Envision Pharma shares her experience of involving patients in medical publishing.
A new poll result published in the MAP newsletter explores the best approach for dealing with a non-responsive lead author.
The MAP newsletter explores an issue faced by medical publication professionals.
Improving gender parity in medical publishing: what’s going on and how you can get involved.
The impact of the AMWA–EMWA–ISMPP Joint Position Statement on the Role of Professional Medical Writers is revealed in the MAP newsletter.
Researchers at Nature uncover the world’s most hyperprolific authors and question our understanding of scientific authorship.
Tim Koder reviews the potential for ORCiD, CRediT and Convey to increase transparency and accountability in medical publishing.
Get up to speed with the latest tips for increasing patient involvement in publications from Elevate Magazine.
How can journals, institutions, funders and societies improve and standardise the current authorship system?